Abstract
It is now almost a decade since the original report of the presence of the Bollum enzyme (terminal deoxynucleotidyl transferase, TdT) in leukemia cells1. That discovery was a fortuitous event which occurred in the course of experiments characterizing what at first appeared to be tumor virus reverse transcriptase in the blast cells of a child with acute lymphoblastic leukemia1,2. The restricted expression of terminal transferase in normal cells had been reported one year earlier by Lucy Chang, working in Fred Bollum’s laboratory3. We interpreted our observation in the light of this restricted expression, postulating that TdT-positive leukemic cells were clonal expansions of TdT-positive normal cell compartments1,4.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. McCaffrey, D. F. Smoler, and D. Baltimore, Terminal deoxy-nucleotidyl transferase in a case of childhood acute lymphoblastic leukemia, Proc Natl Acad Sci USA 70:521 (1973).
R. P. McCaffrey, and D. Baltimore, Detection of reverse transcriptase in cell extracts. Blood 40: 933 (1972).
L. M. S. Chang, Development of terminal deoxnucleotidyl transferase activity in embryonic calf thymus gland, Biochem Biophys Res Common 44: 124 (1971).
R. P. McCaffrey, D. F. Smoler, and D. Baltimore, DNA polymerases in lymphoid cells, in “Modern Trends in Human Leukemia”, R. Neth, R.C. Gallo, S. Spiegelman, and F. Stohlman, eds., J.F. Lehmans Verlag, Munich, Germany (1974).
D. Baltimore, RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature 226:1209 (1970).
H. M. Temin, and S. Mizutani, RNA-dependent DNA polymerase in the virions of Rous sarcoma virus. Nature 226:1211 (1970).
D. Baltimore, R. McCaffrey, and D. F. Smoler, Properties of reverse transcriptase, in: “Virus Research: Proceedings of the 1973 I.C.N.-U.C.L.A. Symposium on Molecular Biology”, C. F. Fox, and W. S. Robinson, eds., Academic Press, New York (1973).
R. P. McCaffrey, D. F. Smoler, T. A. Harrison, and D. Baltimore, A thymus-specific enzyme in acute lymphoblastic leukemia cells, in “Advances in the Biosciences”, T. M. Fliedner, and S. Perry, eds., Pergammon Press, New York (1975).
R. P. McCaffrey, T. A. Harrison, P. C. Kung, R. Parkman, A. E. Silverstone, and D. Baltimore, Terminal deoxy-nucleotidyl transferase in normal and neoplastic hematopoietic cells, in “Modern Trends in Human Leukemia II”, R. Neth, ed., J. F. Lehmans Verlag, Munich, Germany (1976).
R. P. McCaffrey, and D. Baltimore, unpublished observations.
P. C. Kung, J. C. Long, R. P. McCaffrey, R. L. Ratliff, T. A. Harrison, and D. Baltimore, Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma, Am J Med 64:788 (1978).
M. F. Greenwood, M. S. Coleman, J. J. Hutton, B. Lampkin, C. Krill, F. J. Bollum, and P. Holland, Terminal deoxynucleotidyl transferase distribution in neoplastic and hematopoietic cells, J Clin Invest 59:889 (1977).
R. Mertelsmann, B. Koziner, D. Filippa, S. Gupta, B. D. Clarkson, R. A. Good, and F. P. Siegal, Characterization of malignant lymphoma in leukemic phase by multiple differentiation markers of mononuclear cells, Am J Med 63:556 (1977).
M. F. Greaves, Cell surface characteristics of human leukaemic cells, in: “Essays in Biochemistry”, P. N. Campbell, and R. D. Marshall, eds., Academic Press, New York (1979).
F. J. Bollum, Terminal deoxynucleotidyl transferase as a tumor cell marker in leukemia and lymphoma: Results from 1000 patients, in: “Tumor Markers”, Mihich and Baserga, eds., Pergamon Press, Oxford (1979).
S. M. Marks, D. Baltimore, and R. P. McCaffrey, Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia, N Engl J Med 298:812 (1978).
G. P. Canellos, V. T. DeVita, J. Whang-Peng, and P. P. Carbone, Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood 38:671 (1971).
R. McCaffrey, M. Greaves, T. A. Harrison, T. Revezs, M. Beard, and D. Baltimore, Biochemical and immunologial evidence for lymphoblastic conversion in chronic myelogenous leukemia. Blood 46:1044 (1975).
A. V. Hoffbrand, K. Ganeshaguru, G. Janossy, M. F. Greaves, R. K. Woodruff, and D. Catovsky, Terminal deoxynucleotidyl transferase levels and membrane phenotypes in diagnosis of acute leukemia. Lancet ii:520 (1977).
G. Janossy, F. J. Bollum, K. F. Bradstock, and J. Ashley, Cellular phenotypes of normal and leukemic hematopoietic cells determined by analysis with selected antibody combinations. Blood 56:430 (1980).
J. C. Long, R. P. McCaffrey, A. C. Alsenberg, S. M. Marks, and P. C. Rung, Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma. Cancer 44:2127 (1979).
J. A. Donlon, E. S. Jaffe, and R. C. Braylan, Terminal deoxy nucleotidyl transferase activity in malignant lymphomas, N Engl J Med 297:461 (1977).
P. Vezzoni, F. Campagnari, G. DiFronzo, and L. Clerici, Terminal deoxynucleotidyl transferase in human lymphomas: Possible existence of forms with high and low molecular weights, Br J Cancer 43:312 (1981).
B. N. Nathwani, H. Kim, and H. Rappaport, Malignant lympho blastic lymphoma. Cancer 38:964 (1976).
G. Janossy, Personal communication.
K. F. Bradstock, E. S. Papageorgiou, G. Janossy, A. V. Hoff-brand, M. L. Willoughby, P. D. Roberts, and F. J. Bollum, Detection of leukaemic lymphoblasts in CSF by immunofluorescence for terminal nucleotidyl transferase, Lancet i:1144 (1980).
K. F. Bradstock, G. Janossy, A. V. Hoffbrand, K. Ganeshaguru, P. LiemeHin, H. G. Prentice, and F. J. Bollum, Immuno-fluorescent and biochemical studies of terminal deoxynucleotidyl transferase in treated acute leukaemia, Br J Haem 47:121 (1981).
M. Greaves, A. Paxton, G. Janossy, C. Pain, S. Johnson, and T. A. Lister, Acute lymphoblastic leukaemia associated antigen. Ill Alterations in expression during treatment and in relapse, Leukaemia Res 4:1 (1980).
F. J. Bollum, Terminal deoxnucleotidyl transferase as a hematopoietic cell marker, Blood 54:1203 (1979).
R. P. McCaffrey, T. A. Harrison, R. Parkman, and D. Baltimore, Terminal deoxynucleotidyl tansferase activity in human leukemia cells and in normal human erythrocytes, N Engl J Med 292:775 (1975).
D. Baltimore, A. E. Silverstone, P. C. Kung, T. A. Harrison, and R. P. McCaffrey, What cells contain terminal deoxynucleotidyl transferase? “The Generation of Antibody Diversity: A New Look”, A. J. Cunningham, ed., Academic Press, New York (1975).
R. Siegler, and M. A. Rich, Influence of thymic mass on murine viral leukogenesis, Nature 209:313 (1966).
H. T. Abelson, and L. S. Rabstein, Virus-induced thymic independent disease in man. Cancer Res 30:2213 (1970).
M. R. Deibel Jr, and M. S. Coleman, Purification of a high molecular weight human terminal deoxynucleotidyl transferase, J Biol Chem 254:8634 (1979).
M. R. Deibel Jr, M. S. Coleman, K. Acree, and J. J. Hutton, Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia, J Clin Invest 67;725 (1981).
G. Janossy, F. J. Bollum, K. F. Bradstock, A. McMichael, N. Rapson, and M. F. Greaves, Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia, J Immunol 123:1525 (1979).
D. Baltimore, A. E. Silverstone, P. C. Kung, T. A. Harrison, and R. P. McCaffrey, Specialized DNA polymerases in lymphoid cells, in: “Cold Spring Harbor Symposium on Quantitative Biology XLI: Origins of Lymphocyte Diversity”, p.63, (1977).
J. C. Long, and R. P. McCaffrey, Mediastinal mass, N Engl J Med 299:296 (1978).
K. W. Pyke, H.-M. Dosch, M. M. Ipp, and E. W. Gelfand, Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease, N Engl J Med 293:424 (1975).
E. L. Reinhertz, P. C. Kung, G. Goldstein, and S. F. Schlossman, Separation of functional subsets of human T cells by a monoclonal antibody, Proc Natl Acad Sci USA 76:4061 (1979).
G. E. Wright, and N. C. Brown, Inhibitors of Bacillus subtilis polymerase III. Structure-activity relationships of 6-(Phenylhydrazine)uracils, J Medicinal Chem 20:1181 (1977).
N. C. Brown, J. Gambino, and G. E. Wright, Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)- uracils and 6-anilinouracils, J Medicinal Chem 20:9 (1977).
G. E. Wright, E. F. Baril, and N. C. Brown, Butylanilinouracil: A selective inhibitor of HeLa cell DNA synthesis and HeLa cell DNA polymerase alpha. Nucleic Acid Res 1:99 (1980)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
McCaffrey, R., Bell, R., Lillquist, A., Wright, G., Baril, E. (1982). The Bollum Enzyme in Leukemia and Lymphoma Cells: The First Decade. In: Bertazzoni, U., Bollum, F.J. (eds) Terminal Transferase in Immunobiology and Leukemia. Advances in Experimental Medicine and Biology, vol 145. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8929-3_21
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8929-3_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8931-6
Online ISBN: 978-1-4684-8929-3
eBook Packages: Springer Book Archive